NCT02540460View on ClinicalTrials.gov

Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Healthy
Interventions
DRUG

LCB01-0371 800mg

LCB01-0371 800mg

DRUG

LCB01-0371 800mg BID

LCB01-0371 800mg BID

DRUG

LCB01-0371 1200mg BID

LCB01-0371 1200mg BID

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Bundang

Sponsors
All Listed Sponsors
lead

LigaChem Biosciences, Inc.

INDUSTRY

NCT02540460 - Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371 | Biotech Hunter | Biotech Hunter